# A Phase I Study of TS-172 in Healthy Adult Subjects (Single and Multiple Doses)

> **NCT04979572** · PHASE1 · COMPLETED · sponsor: **Taisho Pharmaceutical Co., Ltd.** · enrollment: 41 (actual)

## Conditions studied

- Healthy Adult Subjects

## Interventions

- **DRUG:** TS-172
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04979572
- **Lead sponsor:** Taisho Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-16
- **Primary completion:** 2022-01-26
- **Final completion:** 2022-01-26
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2025-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04979572

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04979572, "A Phase I Study of TS-172 in Healthy Adult Subjects (Single and Multiple Doses)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04979572. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*